Fair point. In short 1.2 billion or 1.3 billion is neither here nor there to me. If they are able to covert the potential revenues into a profit then the shares on offer at 1.3 won’t be a big concern. I’ll be more worried if they were above 2 billion. I. Would be more focused on the North American angle.
They have so many potential re-rating announcements lined up that shares on offer is the least of our concerns.
GMP
Cannepil
Aust license
North America
Malta
Masbult
And who knows ...Korea!!!!
These prices are a great accumulation level. Watch for a pick up in volume which will be a good indicator for the next announcement
Finfeed, page-9
-
- There are more pages in this discussion • 83 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RGT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.0¢ |
Change
0.030(9.38%) |
Mkt cap ! $16.94M | |||
| Open | High | Low | Value | Volume |
| 32.0¢ | 35.0¢ | 32.0¢ | $3.361K | 9.732K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 16739 | 35.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.5¢ | 8746 | 1 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| RGT (ASX) Chart |